Targeting GPX4 alleviates ferroptosis and retards abdominal aortic aneurysm formation

Yu Shi1, Yi Zhao1, Si-Jia Sun1

  • 1Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Biochemical Pharmacology
|February 14, 2025
PubMed

Insights

Ferroptosis, a cell death linked to lipid peroxidation, plays a key role in abdominal aortic aneurysm (AAA). Overexpressing glutathione peroxidase 4 (GPX4) inhibits ferroptosis, preventing AAA progression and inflammation.

Area of Science:

  • Cardiovascular Biology
  • Cell Death Mechanisms
  • Molecular Medicine

Background:

  • Abdominal aortic aneurysm (AAA) is a dangerous cardiovascular condition linked to inflammation and vascular smooth muscle cell (VSMC) loss.
  • Ferroptosis, an iron-dependent cell death, involves lipid peroxidation, but its specific role in AAA pathogenesis is unclear.

Purpose of the Study:

  • To investigate the role of ferroptosis and glutathione peroxidase 4 (GPX4) in abdominal aortic aneurysm (AAA) development.
  • To determine if targeting ferroptosis via GPX4 can prevent AAA progression.

Main Methods:

  • Ferroptosis detection in human AAA tissues, mouse AAA models (elastase- and angiotensin II-induced), and cultured VSMCs.
  • Genetic overexpression of GPX4 to inhibit ferroptosis in AAA models.
  • Analysis of vascular remodeling, inflammatory responses, and macrophage/monocyte activity.
  • In vitro studies on JAK1/STAT3 signaling and macrophage polarization.

Main Results:

  • Ferroptosis was observed in human AAA, experimental mouse AAA, and Ang II-treated VSMCs.
  • GPX4 overexpression significantly reduced vascular remodeling and inflammation in AAA models.
  • GPX4 modulated macrophage migration and activation and inhibited IL-6-induced JAK1/STAT3 signaling in VSMCs.

Conclusions:

  • Ferroptosis is a significant factor in AAA pathogenesis.
  • Therapeutic strategies targeting GPX4 show promise for treating abdominal aortic aneurysms.

Related Concept Videos